Suzuki, S., Yamamoto, M., Togashi, K., Sanomachi, T., Sugai, A., Seino, S., . . . Okada, M. (2019). In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile. Oncotarget.

Suzuki, Shuhei, Masahiro Yamamoto, Keita Togashi, Tomomi Sanomachi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, and Masashi Okada. "In Vitro and in Vivo Anti-tumor Effects of Brexpiprazole, a Newly-developed Serotonin-dopamine Activity Modulator With an Improved Safety Profile." Oncotarget 2019.

Suzuki, Shuhei, et al. "In Vitro and in Vivo Anti-tumor Effects of Brexpiprazole, a Newly-developed Serotonin-dopamine Activity Modulator With an Improved Safety Profile." Oncotarget 2019.